The Leiden University Medical Center (LUMC), as a partner within the reNEW consortium, is once again receiving tens of millions for research into new treatments based on stem cells.
The LUMC announced this.
Novo Nordisk Foundation
The partnership will receive a total of €150 million to develop new treatments in regenerative medicine. The grant is a continuation of earlier funding and runs through 2031. It is made possible by the Novo Nordisk Foundation.
Treatments for patients with Chronic Diseases
Thanks to this investment, LUMC can continue working in the coming years on innovative treatments for patients with chronic diseases. The funding also strengthens LUMC’s position as an international center for stem cell research, collaborating with partners worldwide to improve future healthcare.
Regenerative Medicine
“We are very pleased with the award of the second half of the reNEW funding. This is wonderful recognition of the work accomplished in recent years and of LUMC’s international role in the field of regenerative medicine,” said Marlies Reinders, dean of LUMC.
What is reNEW?
reNEW is an international collaboration in the field of stem cell research. The consortium focuses not only on fundamental research but also places special emphasis on translating new knowledge into practical applications for patients. Within reNEW, LUMC works together with the University of Copenhagen and the Murdoch Children’s Research Institute in Melbourne.
Type 1 Diabetes, Immune Disorders, Kidney Diseases or Heart Failure
Researchers within reNEW aim to develop new therapies for diseases that currently have no effective treatment options. These include chronic illnesses or hereditary conditions such as type 1 diabetes, immune disorders, kidney diseases, and heart failure.
“Continuing the Work of Recent Years“
“Within reNEW, we are working on the medicine of the future in which we not only treat diseases but actually cure them. Thanks to this boost, we can continue our work of recent years and bring our stem cell research from the laboratory closer to the patient,” said Professor Ton Rabelink, director of reNEW in Leiden.
Stem Cells
Stem cells are special cells. They can divide indefinitely and develop into different types of cells in our body, such as heart cells, kidney cells, or nerve cells. This means they may help replace or repair damaged tissue. This field is known as regenerative medicine.
Studying how stem cells work
Researchers at LUMC study exactly how stem cells function and what happens to them in diseased or damaged tissues. They also investigate how these cells can be safely used to repair diseased or damaged organs. Through reNEW, researchers can launch new projects, develop technologies, train young scientists, and translate laboratory discoveries into treatments for patients more quickly.
A boost for LUMC and Leiden
Regenerative medicine is one of LUMC’s strategic focus areas. The center has a long history of leading research in stem cells and the development of disease models and cell and gene therapies. The renewed funding from reNEW is not only a boost for LUMC but for the entire Leiden ecosystem of regenerative medicine.
Leiden Bio Science Park
LUMC is part of the Leiden Bio Science Park, where education, research, companies, and infrastructure come together to not only develop new regenerative treatments but also bring them to patients.
What does this mean for patients?
Stem cell research and regenerative medicine are relatively new fields, and the treatments currently being developed are not yet available to patients. However, this is an important step forward. The first stem cell–based treatments are currently being tested at LUMC and elsewhere in clinical studies to assess their effectiveness and safety. Through international collaboration and additional funding, researchers can accelerate developments and work toward solutions for patients who currently have limited treatment options.
